There’s nothing more annoying than being given the runaround by an interactive voice response system (IVRS). Enter outsourcing firm 24/7, with an IVRS for smartphones and tablets. The IVRS is powered by a speech recognition software that generates lists of options onscreen. The experience is not too different from iPhone’s SIRI, touted as an intelligent voice-recognition interface. “We run the world’s largest self-service system: 2.5 billion interactions annually with customers,” says P.V. Kannan, CEO of 24/7. Last year, the firm backed by Sequoia and Microsoft decided to set up a fresh backend to provide support through smartphones and tablets. In November, it bought San Francisco-based Voxify, one of the largest creators of speech apps. For its clients, 24/7 offers the IVRS as well as the call-centre service, but if the speech recognition model takes off, dependence on call centres could come down. That will truly be the next wave for BPO.
Top Stories
More FromEnterprise
Mahindra Q2 profit races 35% to ₹3,171 cr
Revenue from operations of the automaker accelerated 10% year-on-year to ₹37,689 crore.
Mankind Pharma Q2 profit jumps 29%; chronic segment outperforms
The company reported a stronger-than-expected profit, driven by high demand for its drugs for chronic conditions such as diabetes and cardiovascular diseases.
Titan MD attributes 'depressed Q2 profitability' to customs duty losses, growth investments
After recording a 25% fall in net profit for Q2 FY25, MD Venkat says the company is confident about its performance for the rest of the financial year
Apollo Green Energy plans IPO by 2025; aims to achieve ₹10,000 cr portfolio by next year
The renewable energy arm of Apollo International Group currently manages an order book of ₹3,500 crore across solar and hydro energy.
More FromEnterprise
Mahindra Q2 profit races 35% to ₹3,171 cr
Revenue from operations of the automaker accelerated 10% year-on-year to ₹37,689 crore.
Mankind Pharma Q2 profit jumps 29%; chronic segment outperforms
The company reported a stronger-than-expected profit, driven by high demand for its drugs for chronic conditions such as diabetes and cardiovascular diseases.
Titan MD attributes 'depressed Q2 profitability' to customs duty losses, growth investments
After recording a 25% fall in net profit for Q2 FY25, MD Venkat says the company is confident about its performance for the rest of the financial year
Apollo Green Energy plans IPO by 2025; aims to achieve ₹10,000 cr portfolio by next year
The renewable energy arm of Apollo International Group currently manages an order book of ₹3,500 crore across solar and hydro energy.